Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive
- PMID: 17163756
- DOI: 10.1021/cb600224w
Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive
Abstract
Two recent papers attempt to solve both the tumor selectivity and the in vivo tumor accumulation profiles seen with some Hsp90 inhibitors. They spotlight the higher affinity of ansamycins' hydroquinone over the quinone form for Hsp90 and further discuss its possible contribution to ansamycins' tumor selectivity.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
